Extenze

by Global Products Management · capsule · 30 liquid gel capsules

  • Off the market since February 2022 (NIH)
  • UPC 8 46345 00011 0
  • DSLD label 33209
  • Serving 1 gelcap
  • 30 servings

Extenze by Global Products Management lists 26 ingredients; 26 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on May 23, 2014.

What is in Extenze?

Each row as the label prints it, per serving of 1 gelcap. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Extenze: Supplement Facts rows against the market (DSLD label 33209, January 2026 release)
IngredientAmount% DVAmong products listing it
Extenze Multi Active Blend135 mg
Yohimbe extractin the blend, no amount given
DehydroepiandrosteroneDHEA Note: 98%in the blend, no amount given
Gamma-Aminobutyric AcidGamma-Aminobutyric Acid (Alt. Name: GABA) Note: 98%in the blend, no amount given
Niacinin the blend, no amount given
Velvet Bean extractin the blend, no amount given
Tongkat Ali extractin the blend, no amount given
Tribulus extractin the blend, no amount given
ExtenZe Sexual Response Enhancement BlendExtenZe Sexual Response Enhancement Blend Note: Medically designed proprietary synergistic blend of the finest quality herbal and nutritional Sexual Response Enhancement support ingredients223 mg
Black Pepper extractin the blend, no amount given
Cnidium extractin the blend, no amount given
Damiana extractin the blend, no amount given
DehydroepiandrosteroneDHEA Note: 98%in the blend, no amount given
Gamma-Aminobutyric AcidGamma-Aminobutyric Acid (Alt. Name: GABA) Note: 98%in the blend, no amount given
Korean Ginsengin the blend, no amount given
Barrenwort Extractin the blend, no amount given
L-Arginine HydrochlorideL-Arginine HCl Note: 98%in the blend, no amount given
Licorice extractin the blend, no amount given
Muira Puama extractin the blend, no amount given
PregnenolonePregnenolone Note: 98%in the blend, no amount given
Tribulus extractin the blend, no amount given
Folateas Folic Acidin the blend, no amount given
Yohimbe HClYohimbe HCl Note: 98%in the blend, no amount given
Astragalus extractin the blend, no amount given
Niacinin the blend, no amount given
Tongat Ali Extractin the blend, no amount given
Velvet Bean extractin the blend, no amount given
ChrysinChrysin Note: 98%in the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 33209 (entered May 23, 2014), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 26 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

1 product lists the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: As a dietary supplement, for best results take one liquid gel capsule daily in the morning with breakfast.
Warnings
Allergen Warning: This product contains Lecithin from Soybeans.
Note: If pregnant, lactating or on prescribed medication, consult your physician prior to using this product.
DO NOT USE IF PREGNANT OR NURSING.
Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of prostate cancer, prostate enlargement, heart disease, low "good" cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug.
Do not exceed recommended serving; exceeding may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face in women, aggressiveness, irritability and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health processional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms.
WARNING : NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS.
KEEP OUT OF REACH OF CHILDREN.
Do not use if inner seal is broken.
Storage
Store at 15-30(0) C (59-86(0)F).

Source: label statements in DSLD label 33209.

What else is on the label?

Other ingredients: Liquid Gel Capsule.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): GPM.

How many labels does Extenze have?

One label is on file, entered on May 23, 2014.

  1. Label 33209 (current) Entered May 23, 2014 · off the market February 14, 2022 · 30 liquid gel capsules · UPC 8 46345 00011 0

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Global Products Management (distributor), Pasadena, CA. All Global Products Management products.

Where next?